Covid-19: Tunisia postpones vaccination campaign to March

Posted On 18 February 2021

Number of times this article was read : 121

Tunisia will receive its coronavirus jabs in March, postponing the expected start of its vaccination campaign, a health official said Wednesday. The government had previously announced it was expecting an initial 94,000 doses of Pfizer and AstraZeneca-Oxford jabs to begin arriving from mid-February.

But local media said national vaccine commission member Ahlem Gzara had told parliament on Wednesday that the first doses will arrive next month. Health Minister Faouzi Mehdi meanwhile told private radio that Tunisia will not receive the vaccines until parliament adopts a law under which all liability for potential complications suffered by vaccine recipients would be shouldered by the state.  “These are the conditions required by the laboratories for delivery of the vaccines,” he said.

A bill containing that commitment was approved in a cabinet meeting on Monday and sent to parliament for examination from Friday, the minister added. Tunisia is lagging behind regional peers Morocco and Algeria, which both started their  vaccination campaigns in late January, respectively using the AstraZeneca-Oxford and Russia’s Sputnik V vaccines.

Since the start of the pandemic, Tunisia has recorded 224,329 cases of coronavirus, including 7,617 deaths, according to the health ministry.

AFP
Other Articles in this Week's Issue<< Libya: UN grapples with stubborn presence of mercenaries in LibyaAlgeria: How corruption and bad governance destroy an entire industry >>
The North Africa Journal's WhatsApp Group
.

Most Recent Stories from the Region

Written by The North Africa Journal

The North Africa Journal is a leading English-language publication focused on North Africa. The Journal covers primarily the Maghreb region and expands its general coverage to the Sahel, Egypt, and beyond, when events in those regions affect the broader North Africa geography. The Journal does not have any affiliation with any institution and has been independent since its founding in 1996. Our position is to always bring our best analysis of events affecting the region, and remain as neutral as humanly possible. Our coverage is not limited to one single topic, but ranges from economic and political affairs, to security, defense, social and environmental issues. We rely on our full staff analysts and editors to bring you best-in-class analysis. We also work with sister company MEA Risk LLC, to leverage the presence on the ground of a solid network of contributors and experts. Information on MEA Risk can be found at www.MEA-Risk.com.

Pin It on Pinterest

Share This